{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:36:56Z","timestamp":1791250616856,"version":"4.1.0"},"reference-count":371,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.pharmthera.2016.06.004","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T02:40:02Z","timestamp":1465526402000},"page":"132-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies"],"prefix":"10.1016","volume":"165","author":[{"given":"M.I.G.","family":"Lopez Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Crowston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.A.","family":"Trounce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.06.004_bb0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.0b013e318225ab66","article-title":"Does vigorous exercise have a neuroprotective effect in Parkinson disease?","volume":"77","author":"Ahlskog","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1242\/dmm.020248","article-title":"A mitochondrial therapeutic reverses visual decline in mouse models of diabetes","volume":"8","author":"Alam","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0020","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","article-title":"Oxidants, antioxidants, and the degenerative diseases of aging","volume":"90","author":"Ames","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/bjo.83.2.231","article-title":"Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina","volume":"83","author":"Andrews","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-2-12","article-title":"Metformin directly acts on mitochondria to alter cellular bioenergetics","volume":"2","author":"Andrzejewski","year":"2014","journal-title":"Cancer Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cmet.2013.02.006","article-title":"The mitochondrial RNA-binding protein GRSF1 localizes to RNA granules and is required for posttranscriptional mitochondrial gene expression","volume":"17","author":"Antonicka","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0045","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMra1215233","article-title":"Mitochondrial dynamics\u2014mitochondrial fission and fusion in human diseases","volume":"369","author":"Archer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3856","article-title":"The neuroprotective actions of oestradiol and oestrogen receptors","volume":"16","author":"Arevalo","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.201401070","article-title":"Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and parkin","volume":"206","author":"Ashrafi","year":"2014","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/cdd.2012.81","article-title":"The pathways of mitophagy for quality control and clearance of mitochondria","volume":"20","author":"Ashrafi","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neures.2014.06.007","article-title":"Aerobic exercise effects on neuroprotection and brain repair following stroke: A systematic review and perspective","volume":"87","author":"Austin","year":"2014","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0075","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1093\/hmg\/ddt396","article-title":"Advances in the genomics of common eye diseases","volume":"22","author":"Bailey","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0090","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4321\/S0365-66912007000600012","article-title":"Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy","volume":"82","author":"Barnils","year":"2007","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0100","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.3390\/ijms13067694","article-title":"The role of PPARalpha in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia\/reperfusion in rats","volume":"13","author":"Barreto-Torres","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0105","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjo.2003.027664","article-title":"The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head","volume":"88","author":"Barron","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0110","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1210\/jc.2007-1701","article-title":"Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components","volume":"93","author":"Bastin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/bjo.83.7.867","article-title":"Macular pigment and age related macular degeneration","volume":"83","author":"Beatty","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0120","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0125","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0891-5849(02)01357-6","article-title":"Distribution and breakdown of labeled coenzyme Q10 in rat","volume":"34","author":"Bentinger","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10715760600617843","article-title":"Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics","volume":"40","author":"Bhagavan","year":"2006","journal-title":"Free Radic Res"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2016.06.004_bb0135","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.mito.2007.03.003","article-title":"Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations","volume":"7","author":"Bhagavan","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0005-2728(84)90254-8","article-title":"Specific elution from hydroxylapatite of the mitochondrial phosphate carrier by cardiolipin","volume":"766","author":"Bisaccia","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.molcel.2015.04.028","article-title":"Choosing the right tool for the job: RNAi, TALEN, or CRISPR","volume":"58","author":"Boettcher","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0150","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","article-title":"Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo","volume":"54","author":"Bogacka","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0155","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbabio.2010.01.028","article-title":"RNA turnover in human mitochondria: More questions than answers?","volume":"1797","author":"Borowski","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archopht.120.6.791","article-title":"The distribution of mitochondrial activity in relation to optic nerve structure","volume":"120","author":"Bristow","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2011.02.001","article-title":"There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells","volume":"12","author":"Brown","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0170","doi-asserted-by":"crossref","first-page":"39831","DOI":"10.1074\/jbc.M006476200","article-title":"Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation","volume":"275","author":"Brown","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","article-title":"Disturbed mitochondrial dynamics and neurodegenerative disorders","volume":"11","author":"Burte","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cub.2012.02.005","article-title":"Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons","volume":"22","author":"Cai","year":"2012","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pbb.2003.10.007","article-title":"Methylene blue improves brain oxidative metabolism and memory retention in rats","volume":"77","author":"Callaway","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-genom-082509-141720","article-title":"The mitochondrial proteome and human disease","volume":"11","author":"Calvo","year":"2010","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0195","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/pr.110.003905","article-title":"Targeting sirtuin 1 to improve metabolism: All you need is NAD(+)?","volume":"64","author":"Canto","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/tcrm.2006.2.4.337","article-title":"Brimonidine in the treatment of glaucoma and ocular hypertension","volume":"2","author":"Cantor","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0205","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0210","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awr180","article-title":"Idebenone treatment in Leber's hereditary optic neuropathy","volume":"134","author":"Carelli","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0215","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0197-0186(01)00129-2","article-title":"Optic nerve degeneration and mitochondrial dysfunction: Genetic and acquired optic neuropathies","volume":"40","author":"Carelli","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0225","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0161-6420(01)00618-2","article-title":"Optic neuropathy in Lhon and Leigh syndrome","volume":"108","author":"Carelli","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0230","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000154089","article-title":"Leber's hereditary optic neuroretinopathy and the X-chromosomal susceptibility factor: No linkage to DXs7","volume":"42","author":"Carvalho","year":"1992","journal-title":"Hum Hered"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1442-9071.2012.02773.x","article-title":"Definition of glaucoma: Clinical and experimental concepts","volume":"40","author":"Casson","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0240","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0304-3940(99)00751-X","article-title":"Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease","volume":"275","author":"Cecchi","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0245","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1607-551X(09)70500-5","article-title":"Leber's hereditary opric neuropathy: A case report","volume":"19","author":"Chang","year":"2003","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2012.06.019","article-title":"Effect of valproic acid on mitochondrial epigenetics","volume":"690","author":"Chen","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00291154","article-title":"Preliminary exclusion of an X-linked gene in Leber optic atrophy by linkage analysis","volume":"82","author":"Chen","year":"1989","journal-title":"Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0260","doi-asserted-by":"crossref","first-page":"E1011","DOI":"10.1152\/ajpendo.00508.2003","article-title":"Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells","volume":"286","author":"Chen","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0265","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1167\/iovs.09-4504","article-title":"Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0270","doi-asserted-by":"crossref","first-page":"451","DOI":"10.12809\/hkmj134085","article-title":"Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong","volume":"20","author":"Cheng","year":"2014","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-physiol-021909-135840","article-title":"Genomic analyses of hormone signaling and gene regulation","volume":"72","author":"Cheung","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0280","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.21385","article-title":"Hereditary optic neuropathies share a common mitochondrial coupling defect","volume":"63","author":"Chevrollier","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0285","first-page":"1","article-title":"Targeting mitochondrial function to protect against vision loss","author":"Chhetri","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0290","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/j.jcjo.2013.05.011","article-title":"Comparing EPI-743 treatment in siblings with Leber's hereditary optic neuropathy mt14484 mutation","volume":"48","author":"Chicani","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0295","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.18632\/oncotarget.2632","article-title":"Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro","volume":"5","author":"Chin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ije\/dyr232","article-title":"Epigenetics, epidemiology and mitochondrial DNA diseases","volume":"41","author":"Chinnery","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0305","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.neurobiolaging.2014.01.019","article-title":"Forced exercise protects the aged optic nerve against intraocular pressure injury","volume":"35","author":"Chrysostomou","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2012.09.008","article-title":"Oxidative stress and mitochondrial dysfunction in glaucoma","volume":"13","author":"Chrysostomou","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000316478","article-title":"Mechanisms of retinal ganglion cell injury in aging and glaucoma","volume":"44","author":"Chrysostomou","year":"2010","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/humc.2013.037","article-title":"Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa","volume":"24","author":"Conlon","year":"2013","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0325","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.phytochem.2004.03.005","article-title":"Dietary phytoestrogens and health","volume":"65","author":"Cornwell","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0330","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fncel.2015.00031","article-title":"Mitochondrial dynamism and the pathogenesis of amyotrophic lateral sclerosis","volume":"9","author":"Cozzolino","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0335","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature08958","article-title":"Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease","volume":"465","author":"Craven","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.exer.2015.03.006","article-title":"An acute intraocular pressure challenge to assess retinal ganglion cell injury and recovery in the mouse","volume":"141","author":"Crowston","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0345","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/mtm.2015.3","article-title":"Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss","volume":"2","author":"Cwerman-Thibault","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0350","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/hmg\/ddt450","article-title":"Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation","volume":"23","author":"Dai","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0355","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.exer.2006.10.002","article-title":"Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy","volume":"84","author":"Danylkova","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0360","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1167\/iovs.12-9734","article-title":"Methylene blue protects primary rat retinal ganglion cells from cellular senescence","volume":"53","author":"Daudt","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0365","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4161\/15548627.2014.981920","article-title":"Discovery and implications of transcellular mitophagy","volume":"10","author":"Davis","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2015.07.014","article-title":"Peroxisome proliferator activated receptor-gamma agonists protect oligodendrocyte progenitors against tumor necrosis factor-alpha-induced damage: Effects on mitochondrial functions and differentiation","volume":"271","author":"De Nuccio","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0375","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0380","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial","volume":"6","author":"Di Prospero","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0385","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0390","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1196\/annals.1347.008","article-title":"Development of 17alpha-estradiol as a neuroprotective therapeutic agent: Rationale and results from a phase I clinical study","volume":"1052","author":"Dykens","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0395","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0400","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2011.10.009","article-title":"Initial experience in the treatment of inherited mitochondrial disease with EPI-743","volume":"105","author":"Enns","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0405","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.redox.2014.04.006","article-title":"Oxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathy","volume":"2","author":"Eshaq","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/biof.5520320105","article-title":"Mitochondrial production of reactive oxygen species: Role of complex I and quinone analogues","volume":"32","author":"Fato","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0415","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv140","article-title":"A method for mutagenesis of mouse mtDNA and a resource of mouse mtDNA mutations for modeling human pathological conditions","volume":"43","author":"Fayzulin","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0420","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: Initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0425","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mito.2010.09.003","article-title":"What limits the allotopic expression of nucleus-encoded mitochondrial genes? The case of the chimeric Cox3 and Atp6 genes","volume":"11","author":"Figueroa-Martinez","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0430","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archopht.125.3.434-b","article-title":"No association between variations in the WDR36 gene and primary open-angle glaucoma","volume":"125","author":"Fingert","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0435","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/hmg\/ddr123","article-title":"Copy number variations on chromosome 12q14 in patients with normal tension glaucoma","volume":"20","author":"Fingert","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0440","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000212510","article-title":"Is cell aging caused by respiration-dependent injury to the mitochondrial genome?","volume":"28","author":"Fleming","year":"1982","journal-title":"Gerontology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0445","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0450","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion","volume":"126","author":"Frezza","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0455","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archopht.122.4.532","article-title":"Prevalence of open-angle glaucoma among adults in the United States","volume":"122","author":"Friedman","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0460","doi-asserted-by":"crossref","first-page":"15859","DOI":"10.1523\/JNEUROSCI.0038-12.2012","article-title":"Ectopic vesicular glutamate release at the optic nerve head and axon loss in mouse experimental glaucoma","volume":"32","author":"Fu","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0465","first-page":"82","article-title":"Leber's hereditary optic neuropathy with intracranial arteriovenous malformation: A case report","volume":"102","author":"Fujitake","year":"2002","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0470","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1194\/jlr.R048975","article-title":"Ketogenic diets, mitochondria, and neurological diseases","volume":"55","author":"Gano","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0475","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/eye.2011.309","article-title":"Current concepts on primary open-angle glaucoma genetics: A contribution to disease pathophysiology and future treatment","volume":"26","author":"Gemenetzi","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1096-7192(02)00145-2","article-title":"Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: Rationale and comparative benefits","volume":"77","author":"Geromel","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0485","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1167\/iovs.07-0880","article-title":"Protection against oxidant-induced apoptosis by exogenous glutathione in Leber hereditary optic neuropathy cybrids","volume":"49","author":"Ghelli","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0490","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.04-0777","article-title":"Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma","volume":"46","author":"Gherghel","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0495","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1124\/mol.106.033845","article-title":"The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells","volume":"71","author":"Ghosh","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0500","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1073\/pnas.77.11.6715","article-title":"Maternal inheritance of human mitochondrial DNA","volume":"77","author":"Giles","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0505","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/hmg\/ddr529","article-title":"Mitochondrial autophagy in cells with mtDNA mutations results from synergistic loss of transmembrane potential and mTORC1 inhibition","volume":"21","author":"Gilkerson","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0510","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.3.3.7","article-title":"Methods of retinal ganglion cell differentiation from pluripotent stem cells","volume":"3","author":"Gill","year":"2014","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0515","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber's hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0520","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.364","article-title":"Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways","volume":"6","author":"Giordano","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0530","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nbt.2643","article-title":"Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina","volume":"31","author":"Gonzalez-Cordero","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0535","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1500960","article-title":"Mitochondrial donation\u2014how many women could benefit?","volume":"372","author":"Gorman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0540","first-page":"130","article-title":"Therapeutic strategies for Leber's hereditary optic neuropathy: A current update","volume":"2","author":"Gueven","year":"2013","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0545","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","article-title":"Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10","volume":"4","author":"Gueven","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0550","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/nar\/gkt969","article-title":"No recombination of mtDNA after heteroplasmy for 50 generations in the mouse maternal germline","volume":"42","author":"Hagstrom","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2016.06.004_bb0555","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/116.3.617","article-title":"The mitochondrial DNA transfer RNA(Lys)A\u2192G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA","volume":"116","author":"Hammans","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0560","first-page":"850","article-title":"Carotenoids in the human macula and whole retina","volume":"29","author":"Handelman","year":"1988","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0565","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0570","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1016\/j.bbagen.2013.02.025","article-title":"TMEM126A is a mitochondrial located mRNA (MLR) protein of the mitochondrial inner membrane","volume":"1830","author":"Hanein","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0575","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0161-6420(00)00110-X","article-title":"Ocular histopathologic study of a patient with the T 8993-G point mutation in Leigh's syndrome","volume":"107","author":"Hayashi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0580","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/13543784.2015.1000483","article-title":"Antimalarial compounds in phase II clinical development","volume":"24","author":"Held","year":"2015","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0585","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ajo.2006.02.041","article-title":"A glaucoma case\u2013control study of the WDR36 gene D658G sequence variant","volume":"142","author":"Hewitt","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0590","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/biof.5520320124","article-title":"Safety assessment of coenzyme Q10 (CoQ10)","volume":"32","author":"Hidaka","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0595","first-page":"939","article-title":"Leber hereditary optic neuropathy: Identification of the same mitochondrial ND1 mutation in six pedigrees","volume":"49","author":"Howell","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0600","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00041327-200203000-00036","article-title":"Rapid visual recovery after coenzyme Q10 treatment of leber hereditary optic neuropathy","volume":"22","author":"Huang","year":"2002","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0605","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/aje\/154.2.138","article-title":"Is open-angle glaucoma associated with early menopause? The Rotterdam Study","volume":"154","author":"Hulsman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13816819709057122","article-title":"Optic neuropathy associated with mitochondrial tRNA[Leu(UUR)] A3243G mutation","volume":"18","author":"Hwang","year":"1997","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0615","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","article-title":"Idebenone and neuroprotection: Antioxidant, pro-oxidant, or electron carrier?","volume":"47","author":"Jaber","year":"2015","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0620","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/hmg\/10.2.117","article-title":"Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor","volume":"10","author":"Jacobson","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0625","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbrc.2009.01.038","article-title":"In vitro differentiation of retinal ganglion-like cells from embryonic stem cell derived neural progenitors","volume":"380","author":"Jagatha","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0630","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mam.2012.03.009","article-title":"Consequences of oxidative stress in age-related macular degeneration","volume":"33","author":"Jarrett","year":"2012","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0635","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000316480","article-title":"The importance of mitochondria in age-related and inherited eye disorders","volume":"44","author":"Jarrett","year":"2010","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0640","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1167\/iovs.13-12968","article-title":"Mitochondrial DNA variant discovery in normal-tension glaucoma patients by next-generation sequencing","volume":"55","author":"Jeoung","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0645","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0650","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.1993.01090040087038","article-title":"Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation","volume":"111","author":"Johns","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0655","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0006-291X(92)90479-5","article-title":"An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy","volume":"187","author":"Johns","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0660","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1244360","article-title":"mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome","volume":"342","author":"Johnson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0665","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1167\/iovs.09-4509","article-title":"Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma","volume":"51","author":"Johnson","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0670","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/awt292","article-title":"Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome","volume":"137","author":"Johnson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0675","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/1055-9965.EPI-04-0398","article-title":"Resveratrol-induced gene expression profiles in human prostate cancer cells","volume":"14","author":"Jones","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0680","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1167\/iovs.08-2499","article-title":"Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina","volume":"50","author":"Ju","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0685","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1167\/iovs.06-0573","article-title":"Elevated hydrostatic pressure triggers mitochondrial fission and decreases cellular ATP in differentiated RGC-5 cells","volume":"48","author":"Ju","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0690","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2217\/fnl.11.14","article-title":"Modeling neurological diseases using patient-derived induced pluripotent stem cells","volume":"6","author":"Juopperi","year":"2011","journal-title":"Future Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0695","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nchembio727","article-title":"Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors","volume":"1","author":"Kagan","year":"2005","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0700","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/bph.12456","article-title":"Development of pharmacological strategies for mitochondrial disorders","volume":"171","author":"Kanabus","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0705","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2147\/OPTH.S3361","article-title":"Hypoxia-ischemia and retinal ganglion cell damage","volume":"2","author":"Kaur","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0710","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007791.pub3","article-title":"Antioxidants and other pharmacological treatments for Friedreich ataxia","volume":"4","author":"Kearney","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0715","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s13311-013-0176-7","article-title":"Review of clinical trials for mitochondrial disorders: 1997\u20132012","volume":"10","author":"Kerr","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0720","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnagi.2013.00048","article-title":"Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration","volume":"5","author":"Kincaid","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0725","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1021\/bi802282h","article-title":"Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (complex I) and production of reactive oxygen species","volume":"48","author":"King","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0730","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/brain\/awp158","article-title":"Gene\u2013environment interactions in Leber hereditary optic neuropathy","volume":"132","author":"Kirkman","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0735","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/jcb.21936","article-title":"Estrogenic control of mitochondrial function and biogenesis","volume":"105","author":"Klinge","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0740","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/aws279","article-title":"Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy","volume":"136","author":"Klopstock","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0745","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0750","first-page":"2105","article-title":"Estrogen receptor expression in bovine and rat retinas","volume":"39","author":"Kobayashi","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0755","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/IJG.0b013e318181284f","article-title":"Mitochondrial dysfunction and glaucoma","volume":"18","author":"Kong","year":"2009","journal-title":"J Glaucoma"},{"issue":"1126","key":"10.1016\/j.pharmthera.2016.06.004_bb0760","first-page":"e1115","article-title":"Impact of aging and diet restriction on retinal function during and after acute intraocular pressure injury","volume":"33","author":"Kong","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0765","doi-asserted-by":"crossref","first-page":"C1440","DOI":"10.1152\/ajpcell.00607.2004","article-title":"Inhibition of complex I of the electron transport chain causes O2--mediated mitochondrial outgrowth","volume":"288","author":"Koopman","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbabio.2009.10.003","article-title":"Patients with Leber hereditary optic neuropathy fail to compensate impaired oxidative phosphorylation","volume":"1797","author":"Korsten","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0775","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0780","doi-asserted-by":"crossref","first-page":"13534","DOI":"10.1073\/pnas.1109263108","article-title":"Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA","volume":"108","author":"Kukat","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0785","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archophthalmol.2010.201","article-title":"Leber hereditary optic neuropathy gene therapy clinical trial recruitment: Year 1","volume":"128","author":"Lam","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0790","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0079-6123(09)17502-7","article-title":"Strategies for retinal repair: Cell replacement and regeneration","volume":"175","author":"Lamba","year":"2009","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0795","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev-biochem-060408-093701","article-title":"Somatic mitochondrial DNA mutations in mammalian aging","volume":"79","author":"Larsson","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0800","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mito.2011.11.004","article-title":"Mitochondrial dysfunction in glaucoma: Understanding genetic influences","volume":"12","author":"Lascaratos","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0805","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/bjo.87.11.1324","article-title":"Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study","volume":"87","author":"Lee","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0810","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1167\/iovs.13-12564","article-title":"Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma","volume":"55","author":"Lee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0815","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1167\/iovs.12-9596","article-title":"Impaired complex-I-linked respiration and ATP synthesis in primary open-angle glaucoma patient lymphoblasts","volume":"53","author":"Lee","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0820","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.exer.2010.07.015","article-title":"Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies","volume":"93","author":"Lee","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0825","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1750-1172-7-46","article-title":"Dominant optic atrophy","volume":"7","author":"Lenaers","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0830","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.biocel.2009.04.013","article-title":"OPA1 functions in mitochondria and dysfunctions in optic nerve","volume":"41","author":"Lenaers","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0835","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1167\/iovs.09-4310","article-title":"Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection","volume":"51","author":"Levkovitch-Verbin","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0840","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00417-008-1009-y","article-title":"Effects of bone-marrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia\/reperfusion","volume":"247","author":"Li","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0845","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1152\/physrev.00030.2008","article-title":"Mitochondrial dynamics in mammalian health and disease","volume":"89","author":"Liesa","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0850","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1167\/iovs.10-6894","article-title":"Current prospects in optic nerve protection and regeneration: Sixth ARVO\/Pfizer Ophthalmics Research Institute Conference","volume":"52","author":"Limb","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0855","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0860","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0865","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.bbabio.2015.04.010","article-title":"Mitochondria, autophagy and age-associated neurodegenerative diseases: New insights into a complex interplay","volume":"1847","author":"Lionaki","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0870","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajhg.2009.11.018","article-title":"No evidence of association of heterozygous NTF4 mutations in patients with primary open-angle glaucoma","volume":"86","author":"Liu","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0875","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","article-title":"Fasting: Molecular mechanisms and clinical applications","volume":"19","author":"Longo","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0880","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nature14546","article-title":"Metabolic rescue in pluripotent cells from patients with mtDNA disease","volume":"524","author":"Ma","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0885","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainresrev.2008.09.002","article-title":"The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies","volume":"59","author":"Maalouf","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0890","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2006.11.065","article-title":"Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation","volume":"145","author":"Maalouf","year":"2007","journal-title":"Neuroscience"},{"issue":"Pt 4","key":"10.1016\/j.pharmthera.2016.06.004_bb0895","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/eye.1994.102","article-title":"Three subgroups of patients from the United Kingdom with Leber hereditary optic neuropathy","volume":"8","author":"Mackey","year":"1994","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0900","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/ICU.0000000000000090","article-title":"Genome-wide association study success in ophthalmology","volume":"25","author":"Mackey","year":"2014","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0905","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev.biochem.77.061206.171059","article-title":"Aging and survival: the genetics of life span extension by dietary restriction","volume":"77","author":"Mair","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0910","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awm114","article-title":"Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy","volume":"130","author":"Malfatti","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0915","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nmeth.2649","article-title":"Cas9 as a versatile tool for engineering biology","volume":"10","author":"Mali","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0920","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the north east of England","volume":"72","author":"Man","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0925","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jmg.39.3.162","article-title":"Leber hereditary optic neuropathy","volume":"39","author":"Man","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0930","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.0b013e318294b44c","article-title":"Phenotypic heterogeneity of the 8344A>G mtDNA \u201cMERRF\u201d mutation","volume":"80","author":"Mancuso","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0935","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.bbadis.2013.09.005","article-title":"MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis","volume":"1832","author":"Mao","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0940","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: An emerging problem in clinical medicine","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0945","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00041327-200020030-00006","article-title":"Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?","volume":"20","author":"Mashima","year":"2000","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0950","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0955","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bcp.2007.10.019","article-title":"Effects of memantine on mitochondrial function","volume":"75","author":"McAllister","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0960","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1152\/physrev.00010.2007","article-title":"Estradiol and the developing brain","volume":"88","author":"McCarthy","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0965","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/humu.22694","article-title":"Capture of somatic mtDNA point mutations with severe effects on oxidative phosphorylation in synaptosome cybrid clones from human brain","volume":"35","author":"McKenzie","year":"2014","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0970","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease","volume":"31","author":"McManus","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0975","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.scr.2015.02.003","article-title":"Stem cell treatment of degenerative eye disease","volume":"14","author":"Mead","year":"2015","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0980","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2011.06.051","article-title":"The human mitochondrial transcriptome","volume":"146","author":"Mercer","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0985","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/stem.674","article-title":"Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment","volume":"29","author":"Meyer","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0990","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn3380","article-title":"Axonal transport deficits and neurodegenerative diseases","volume":"14","author":"Millecamps","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb0995","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(04)17517-X","article-title":"The eye in neurological disease","volume":"364","author":"Miller","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1000","doi-asserted-by":"crossref","first-page":"19689","DOI":"10.1073\/pnas.0609502103","article-title":"Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase","volume":"103","author":"Minczuk","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tem.2013.09.001","article-title":"Clinical and ethical implications of mitochondrial gene transfer","volume":"25","author":"Mitalipov","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archopht.124.8.1151","article-title":"Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative","volume":"124","author":"Moeller","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/kfn021","article-title":"Genistein is an efficient estrogen in the whole-body throughout mouse development","volume":"103","author":"Montani","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/tx970136j","article-title":"Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone)","volume":"11","author":"Mordente","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.eye.6701574","article-title":"Circulation and axonal transport in the optic nerve","volume":"18","author":"Morgan","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1030","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1442-9071.2012.02789.x","article-title":"Retina ganglion cell degeneration in glaucoma: An opportunity missed? A review","volume":"40","author":"Morgan","year":"2012","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjo.85.7.877","article-title":"Presence of oestrogen receptor type beta in human retina","volume":"85","author":"Munaut","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1040","first-page":"60","article-title":"Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection","volume":"6","author":"Munemasa","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1045","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/j.1471-4159.2010.07057.x","article-title":"Modulation of mitochondria in the axon and soma of retinal ganglion cells in a rat glaucoma model","volume":"115","author":"Munemasa","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1060","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0006-3223(88)90229-6","article-title":"Methylene blue in mania","volume":"24","author":"Naylor","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cmet.2015.05.011","article-title":"Understanding the cellular and molecular mechanisms of physical activity-induced health benefits","volume":"22","author":"Neufer","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1070","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","article-title":"Hereditary optic neuropathies","volume":"18","author":"Newman","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2005.03.058","article-title":"Prophylaxis for second eye involvement in leber hereditary optic neuropathy: An open-labeled, nonrandomized multicenter trial of topical brimonidine purite","volume":"140","author":"Newman","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1080","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0002-9394(14)76784-4","article-title":"The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation","volume":"111","author":"Newman","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1085","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.341","article-title":"Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes","volume":"4","author":"Noh","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/eye.2011.291","article-title":"Ophthalmic features of Friedreich ataxia","volume":"26","author":"Noval","year":"2012","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1134\/S0006297914100113","article-title":"Preventive and therapeutic effects of SkQ1-containing Visomitin eye drops against light-induced retinal degeneration","volume":"79","author":"Novikova","year":"2014","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbagen.2011.08.001","article-title":"Mitochondria and autophagy: Critical interplay between the two homeostats","volume":"1820","author":"Okamoto","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.gde.2012.05.005","article-title":"New lessons learned from disease modeling with induced pluripotent stem cells","volume":"22","author":"Onder","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016347","article-title":"Biophysical characterization of the olfactomedin domain of myocilin, an extracellular matrix protein implicated in inherited forms of glaucoma","volume":"6","author":"Orwig","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nbt1384","article-title":"Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells","volume":"26","author":"Osakada","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature14300","article-title":"Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans","volume":"521","author":"Palikaras","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exger.2014.01.021","article-title":"Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis","volume":"56","author":"Palikaras","year":"2014","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbabio.2013.10.006","article-title":"Functional role of cardiolipin in mitochondrial bioenergetics","volume":"1837","author":"Paradies","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1135","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/stem.320","article-title":"Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: Therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration","volume":"28","author":"Parameswaran","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026989","article-title":"Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor gamma coactivator-1alpha","volume":"6","author":"Pardo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3341\/kjo.2012.26.2.84","article-title":"Circulating total glutathione in normal tension glaucoma patients: Comparison with normal control subjects","volume":"26","author":"Park","year":"2012","journal-title":"Korean J Ophthalmol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2016.06.004_bb1150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.12322","article-title":"Co-enzyme Q10 and idebenone use in Friedreich's ataxia","volume":"126","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","article-title":"A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: No evidence of benefit","volume":"71","author":"Parkinson Study Group, Q. E. I.","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1165","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IJG.0b013e318064c82d","article-title":"Attributes of female reproductive aging and their relation to primary open-angle glaucoma: A prospective study","volume":"16","author":"Pasquale","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1170","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ymgme.2013.03.011","article-title":"Glutathione: A redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies","volume":"109","author":"Pastore","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ajhg.2009.08.016","article-title":"Heterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucoma","volume":"85","author":"Pasutto","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature11800","article-title":"Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants","volume":"493","author":"Paull","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1185","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1091\/mbc.E05-11-1013","article-title":"Functional estrogen receptors in the mitochondria of breast cancer cells","volume":"17","author":"Pedram","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/nar\/gkq769","article-title":"Allotopic expression of mitochondrial-encoded genes in mammals: Achieved goal, undemonstrated mechanism or impossible task?","volume":"39","author":"Perales-Clemente","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.06.011","article-title":"The eye: A window to the soul of the immune system","volume":"45","author":"Perez","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01217304","article-title":"Evidence that the lamina cribrosa prevents intraretinal myelination of retinal ganglion cell axons","volume":"19","author":"Perry","year":"1990","journal-title":"J Neurocytol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mce.2013.12.017","article-title":"Non-feminizing estrogens: A novel neuroprotective therapy","volume":"389","author":"Petrone","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12325-015-0274-5","article-title":"SkQ1 ophthalmic solution for dry eye treatment: Results of a phase 2 safety and efficacy clinical study in the environment and during challenge in the controlled adverse environment model","volume":"33","author":"Petrov","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13105-012-0159-x","article-title":"Estrogens: Mechanisms of neuroprotective effects","volume":"68","author":"Petrovska","year":"2012","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1220","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatments for mitochondrial disease\u2014No time to drop our standards","volume":"9","author":"Pfeffer","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1225","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004426.pub3","article-title":"Treatment for mitochondrial disorders","volume":"4","author":"Pfeffer","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1230","doi-asserted-by":"crossref","first-page":"E4033","DOI":"10.1073\/pnas.1414028111","article-title":"Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming","volume":"111","author":"Picard","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1235","first-page":"6921","article-title":"Targeting estrogen receptor beta as preventive therapeutic strategy for Leber's hereditary optic neuropathy","volume":"24","author":"Pisano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1240","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1093\/emboj\/18.23.6694","article-title":"NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase","volume":"18","author":"Pomerantz","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048279","article-title":"Neuroprotective actions of methylene blue and its derivatives","volume":"7","author":"Poteet","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1250","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00417-006-0269-7","article-title":"Leber's hereditary optic neuropathy and vitamin B12 deficiency","volume":"244","author":"Pott","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1255","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/mp400313u","article-title":"17beta-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma","volume":"10","author":"Prokai-Tatrai","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1260","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1074\/jbc.R111.304428","article-title":"Loss of daylight vision in retinal degeneration: Are oxidative stress and metabolic dysregulation to blame?","volume":"287","author":"Punzo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1265","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejhg.5201828","article-title":"Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland","volume":"15","author":"Puomila","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.06-0789","article-title":"The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse","volume":"48","author":"Qi","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1275","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","article-title":"Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation","volume":"12","author":"Qiu","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1280","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1285","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.eye.6701577","article-title":"Stem cells to replace the optic nerve","volume":"18","author":"Quigley","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1290","doi-asserted-by":"crossref","first-page":"25628","DOI":"10.1074\/jbc.M804291200","article-title":"Rosiglitazone treatment prevents mitochondrial dysfunction in mutant Huntingtin-expressing cells: Possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease","volume":"283","author":"Quintanilla","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1295","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/wrna.1128","article-title":"The human mitochondrial transcriptome and the RNA-binding proteins that regulate its expression","volume":"3","author":"Rackham","year":"2012","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1300","doi-asserted-by":"crossref","first-page":"259","DOI":"10.33549\/physiolres.932318","article-title":"Idebenone-induced recovery of glycerol-3-phosphate and succinate oxidation inhibited by digitonin","volume":"61","author":"Rauchova","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1305","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1310","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","article-title":"Selective elimination of mitochondrial mutations in the germline by genome editing","volume":"161","author":"Reddy","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biocel.2014.05.010","article-title":"Mitophagy mechanisms and role in human diseases","volume":"53","author":"Redmann","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1320","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/74447","article-title":"Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro","volume":"18","author":"Reubinoff","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1325","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1066901","article-title":"Adult-onset primary open-angle glaucoma caused by mutations in optineurin","volume":"295","author":"Rezaie","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1330","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5966\/sctm.2013-0147","article-title":"Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells","volume":"3","author":"Riazifar","year":"2014","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fphar.2014.00151","article-title":"Glutathione and mitochondria","volume":"5","author":"Ribas","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1340","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaophthalmol.2014.104","article-title":"TBK1 gene duplication and normal-tension glaucoma","volume":"132","author":"Ritch","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1345","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4161\/auto.8.2.18982","article-title":"Axonal damage, autophagy and neuronal survival","volume":"8","author":"Rodriguez-Muela","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1350","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pneurobio.2011.10.007","article-title":"Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue","volume":"96","author":"Rojas","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12640-009-9027-z","article-title":"Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy","volume":"15","author":"Rojas","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/WNO.0b013e318272c643","article-title":"Effects of idebenone on color vision in patients with Leber hereditary optic neuropathy","volume":"33","author":"Rudolph","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1365","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0079-6123(08)01144-8","article-title":"17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat","volume":"173","author":"Russo","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","article-title":"Leber's hereditary optic neuropathy","volume":"13","author":"Sadun","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1380","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1083\/jcb.200501162","article-title":"Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis","volume":"169","author":"Sahlender","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1385","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.4161\/cc.10.17.17060","article-title":"RNA processing in human mitochondria","volume":"10","author":"Sanchez","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1390","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/me.2014-1077","article-title":"Estrogen-mediated regulation of mitochondrial gene expression","volume":"29","author":"Sanchez","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1395","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/138920111794480507","article-title":"Diabetic retinopathy, superoxide damage and antioxidants","volume":"12","author":"Santos","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1400","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1134\/S0006297912060120","article-title":"SkQ1 slows development of age-dependent destructive processes in retina and vascular layer of eyes of Wistar and OXYS rats","volume":"77","author":"Saprunova","year":"2012","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1405","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1091\/mbc.E10-01-0047","article-title":"LRPPRC and SLIRP interact in a ribonucleoprotein complex that regulates posttranscriptional gene expression in mitochondria","volume":"21","author":"Sasarman","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1410","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.bbamcr.2013.03.010","article-title":"Maternal inheritance of mitochondrial DNA by diverse mechanisms to eliminate paternal mitochondrial DNA","volume":"1833","author":"Sato","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1415","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1242\/jcs.053850","article-title":"The axonal transport of mitochondria","volume":"125","author":"Saxton","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1420","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1196\/annals.1427.006","article-title":"Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator","volume":"1147","author":"Scarpulla","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1425","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The epidemiology of mitochondrial disorders\u2014Past, present and future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1430","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.febslet.2006.07.022","article-title":"Barth syndrome, a human disorder of cardiolipin metabolism","volume":"580","author":"Schlame","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yfrne.2011.10.001","article-title":"Estrogen neuroprotection and the critical period hypothesis","volume":"33","author":"Scott","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1445","doi-asserted-by":"crossref","first-page":"16510","DOI":"10.1073\/pnas.1119738109","article-title":"Mammalian transcription factor A is a core component of the mitochondrial transcription machinery","volume":"109","author":"Shi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1450","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/10.20.2277","article-title":"Nuclear genetic defects of oxidative phosphorylation","volume":"10","author":"Shoubridge","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1455","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1016\/j.bmcl.2011.04.085","article-title":"alpha-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging","volume":"21","author":"Shrader","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1460","first-page":"572634","article-title":"Oxidative stress in neurodegeneration","volume":"2011","author":"Shukla","year":"2011","journal-title":"Adv Pharm Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1465","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/em.20571","article-title":"A compendium of human mitochondrial gene expression machinery with links to disease","volume":"51","author":"Shutt","year":"2010","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1470","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000338409","article-title":"Neuroprotection and estrogen receptors","volume":"96","author":"Simpkins","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1480","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbagen.2009.11.013","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"1800","author":"Simpkins","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1485","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymgme.2014.03.006","article-title":"Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts","volume":"112","author":"Sitarz","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1490","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1128\/MCB.25.15.6427-6435.2005","article-title":"Polyadenylation and degradation of human mitochondrial RNA: The prokaryotic past leaves its mark","volume":"25","author":"Slomovic","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1495","doi-asserted-by":"crossref","first-page":"16595","DOI":"10.1038\/srep16595","article-title":"Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line","volume":"5","author":"Sluch","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1500","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35072063","article-title":"The genetics and pathology of oxidative phosphorylation","volume":"2","author":"Smeitink","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1505","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1001\/archopht.1993.01090110052022","article-title":"Heteroplasmy in Leber's hereditary optic neuropathy","volume":"111","author":"Smith","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1510","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/mds.23148","article-title":"A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease","volume":"25","author":"Snow","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1515","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.freeradbiomed.2010.05.009","article-title":"Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide","volume":"49","author":"Song","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1520","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ajo.2005.11.007","article-title":"Influence of mutation type on clinical expression of Leber hereditary optic neuropathy","volume":"141","author":"Spruijt","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1525","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ddr.21258","article-title":"Bioprotective carnitinoids: Lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: Mitochondrial drugs come of age","volume":"76","author":"Steliou","year":"2015","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1530","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrg3764","article-title":"Investigating human disease using stem cell models","volume":"15","author":"Sterneckert","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1535","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/mol.105.014662","article-title":"Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels","volume":"68","author":"Stirone","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"1985","key":"10.1016\/j.pharmthera.2016.06.004_bb1540","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/japplphysiol.00255.2006","article-title":"Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo","volume":"101","author":"Suwa","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1545","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the discovery of novel compounds that restore mitochondrial plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1550","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature11647","article-title":"Towards germline gene therapy of inherited mitochondrial diseases","volume":"493","author":"Tachibana","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1555","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature08368","article-title":"Mitochondrial gene replacement in primate offspring and embryonic stem cells","volume":"461","author":"Tachibana","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1560","first-page":"2258","article-title":"Expression and cellular localization of estrogen receptors alpha and beta in the human fetus","volume":"86","author":"Takeyama","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1565","doi-asserted-by":"crossref","first-page":"10515","DOI":"10.1073\/pnas.1509879112","article-title":"In vivo imaging of axonal transport of mitochondria in the diseased and aged mammalian CNS","volume":"112","author":"Takihara","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1570","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2007.03.083","article-title":"Dietary antioxidants and the long-term incidence of age-related macular degeneration: The Blue Mountains Eye Study","volume":"115","author":"Tan","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1575","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1038\/srep08344","article-title":"Generation of retinal ganglion cells with functional axons from human induced pluripotent stem cells","volume":"5","author":"Tanaka","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1580","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1475-2840-11-140","article-title":"Balanced pan-PPAR activator bezafibrate in combination with statin: Comprehensive lipids control and diabetes prevention?","volume":"11","author":"Tenenbaum","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1585","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1167\/iovs.08-2717","article-title":"The role of glia, mitochondria, and the immune system in glaucoma","volume":"50","author":"Tezel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1590","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063446","article-title":"Raised intraocular pressure as a potential risk factor for visual loss in Leber hereditary optic neuropathy","volume":"8","author":"Thouin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1600","first-page":"536","article-title":"Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man","volume":"24","author":"Tomono","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1605","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1517\/14656566.9.13.2327","article-title":"Idebenone in Friedreich's ataxia","volume":"9","author":"Tonon","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1610","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/nar\/28.10.2164","article-title":"Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells","volume":"28","author":"Trounce","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1615","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/jn\/129.12.2113","article-title":"Blood concentration of coenzyme Q(10) increases in rats when esterified forms are administered","volume":"129","author":"Turunen","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1620","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1625","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/ICU.0b013e3283360b7e","article-title":"Gender and glaucoma: What we know and what we need to know","volume":"21","author":"Vajaranant","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1630","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.freeradbiomed.2004.02.013","article-title":"Reactive oxygen species induce different cell death mechanisms in cultured neurons","volume":"36","author":"Valencia","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140919","article-title":"Measurement of systemic mitochondrial function in advanced primary open-angle glaucoma and Leber hereditary optic neuropathy","volume":"10","author":"Van Bergen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1640","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021347","article-title":"Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy","volume":"6","author":"Van Bergen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1645","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ene.12341","article-title":"EFNS\/ENS consensus on the diagnosis and management of chronic ataxias in adulthood","volume":"21","author":"van de Warrenburg","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1650","doi-asserted-by":"crossref","first-page":"15139","DOI":"10.1523\/JNEUROSCI.2814-14.2014","article-title":"Exercise, energy intake, glucose homeostasis, and the brain","volume":"34","author":"van Praag","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061396","article-title":"AAV-mediated gene therapy for choroideremia: Preclinical studies in personalized models","volume":"8","author":"Vasireddy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia\u2013neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1665","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mito.2013.01.008","article-title":"Mitochondrial metabolism of reactive oxygen species","volume":"13","author":"Venditti","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1670","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-5793(97)00767-9","article-title":"Stimulation of respiration by methylene blue in rat liver mitochondria","volume":"412","author":"Visarius","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1675","doi-asserted-by":"crossref","first-page":"a021220","DOI":"10.1101\/cshperspect.a021220","article-title":"Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease","volume":"5","author":"Wallace","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1680","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mito.2009.09.006","article-title":"Energetics, epigenetics, mitochondrial genetics","volume":"10","author":"Wallace","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1685","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1690","doi-asserted-by":"crossref","first-page":"21587","DOI":"10.1038\/srep21587","article-title":"Efficacy and safety of rAAV2-ND4 treatment for Leber's hereditary optic neuropathy","volume":"6","author":"Wan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1695","doi-asserted-by":"crossref","first-page":"a017244","DOI":"10.1101\/cshperspect.a017244","article-title":"Common and rare genetic risk factors for glaucoma","volume":"4","author":"Wang","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1700","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nbt.3127","article-title":"Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors","volume":"33","author":"Wang","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1705","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409238.2012.741564","article-title":"Molecular genetics of ubiquinone biosynthesis in animals","volume":"48","author":"Wang","year":"2013","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1710","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1074\/jbc.M110.208447","article-title":"Alternative mitochondrial electron transfer as a novel strategy for neuroprotection","volume":"286","author":"Wen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1715","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/iub.261","article-title":"PGC-1alpha activation as a therapeutic approach in mitochondrial disease","volume":"61","author":"Wenz","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1720","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2008.07.006","article-title":"Activation of the PPAR\/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype","volume":"8","author":"Wenz","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1725","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/dom.12388","article-title":"Pioglitazone treatment restores in vivo muscle oxidative capacity in a rat model of diabetes","volume":"17","author":"Wessels","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1730","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1735","doi-asserted-by":"crossref","first-page":"E4439","DOI":"10.1073\/pnas.1405752111","article-title":"Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation","volume":"111","author":"Wong","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1740","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","article-title":"Induced pluripotent stem cells: past, present, and future","volume":"10","author":"Yamanaka","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1745","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1073\/pnas.0306948101","article-title":"Mitochondrial localization of estrogen receptor beta","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb9000","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","article-title":"The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment","volume":"4","author":"Yarosh","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1750","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1755","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2010.11.058","article-title":"The assessment of non-feminizing estrogens for use in neuroprotection","volume":"1379","author":"Yi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1760","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5115\/acb.2010.43.2.97","article-title":"Re-engineering the mitochondrial genomes in mammalian cells","volume":"43","author":"Yoon","year":"2010","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1765","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/eye.2011.2","article-title":"Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations","volume":"25","author":"Yu-Wai-Man","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1770","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1775","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: Past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1780","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.exer.2005.01.018","article-title":"Retinal degeneration and local oxygen metabolism","volume":"80","author":"Yu","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1785","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.preteyeres.2013.07.001","article-title":"Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability","volume":"36","author":"Yu","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1790","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbrc.2006.03.231","article-title":"Effects of bone marrow stromal cell injection in an experimental glaucoma model","volume":"344","author":"Yu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1795","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.mehy.2004.10.021","article-title":"Optic neuropathies\u2014importance of spatial distribution of mitochondria as well as function","volume":"65","author":"Yu Wai Man","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1800","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.cell.2012.12.029","article-title":"Vesicular glycolysis provides on-board energy for fast axonal transport","volume":"152","author":"Zala","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1805","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1810","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF03033307","article-title":"Methylene blue prevents neurodegeneration caused by rotenone in the retina","volume":"9","author":"Zhang","year":"2006","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1815","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jn\/125.3.446","article-title":"Uptake of dietary coenzyme Q supplement is limited in rats","volume":"125","author":"Zhang","year":"1995","journal-title":"J Nutr"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1820","doi-asserted-by":"crossref","first-page":"34682","DOI":"10.1074\/jbc.M402999200","article-title":"Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury","volume":"279","author":"Zhao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1825","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00417-011-1635-7","article-title":"Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats","volume":"249","author":"Zhao","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1830","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/ncomms5047","article-title":"Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs","volume":"5","author":"Zhong","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1835","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/dneu.20373","article-title":"Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma","volume":"67","author":"Zhou","year":"2007","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1840","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4161\/auto.24135","article-title":"After the banquet: mitochondrial biogenesis, mitophagy, and cell survival","volume":"9","author":"Zhu","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1845","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnagi.2015.00101","article-title":"Implications of mitochondrial dynamics on neurodegeneration and on hypothalamic dysfunction","volume":"7","author":"Zorzano","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharmthera.2016.06.004_bb1850","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.expneurol.2008.12.028","article-title":"Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model","volume":"216","author":"Zwart","year":"2009","journal-title":"Exp Neurol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0163725816300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T21:15:35Z","timestamp":1748985335000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":371,"alternative-id":["S0163725816300948"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.06.004","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.pharmthera.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}